3 completed, 2 terminated, 2 unknown, 1 withdrawn. 8 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 3, Terminated 2, Unknown 2, Withdrawn 1 |
| Phase 2 | 4 | Completed 2, Terminated 1, Unknown 1 |
Follow Olfaction Disorders: new trials by email Literature Review of Olfaction Disorders trials Research Report on Olfaction Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Theophylline Nasal Spray for PD-Related Hyposmia and Anosmia CYR-064 - Hyposmia, Anosmia | Phase 1 | Withdrawn | University of Nebraska | 2025-04-01 | 2025-03-13 | |
| Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction Stellate Ganglion Block - Anosmia, Hyposmia | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 20 | 2022-09-01 | 2026-02-12 |
| Preparation and Characterization Intranasal Film Loaded With Steroid as a Local Treatment of Anosmia in Compare to Insulin Intranasal Film Prednisolone - Smell Loss | Phase 1 / Phase 2 | Completed | Deraya University | 200 | 2022-03-01 | 2023-06-01 |
| The Study of Quadruple Therapy Intranasal Insulin, Zinc, Gabapentin, Ice Cube Stimulation for Post COVID-19 Smell and Taste Dysfunctions Insulin aspart - Smell Dysfunction, Taste Disorders | Phase 1 | Unknown | Ministry of Health, Saudi Arabia | 22 | 2021-12-26 | 2021-11-03 |
| Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19 Smell Retraining, Budesonide - Dysosmia, Anosmia | Phase 1 / Phase 2 | Terminated | Amanda Stapleton | 20 | 2021-09-30 | 2024-06-13 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 PurWet, FurFat, PurApo - Sequelae of; Infection, Post Infection Glomerulonephritis | Phase 1 / Phase 2 | Unknown | All Natural Medicine Clinic, LLC | 2000 | 2021-03-01 | 2021-05-26 |
| Evaluate a Medication on How Hunger and Appetite Are Influenced by Smell Placebo spray, Diltiazem - Food Intake | Phase 1 | Terminated | Pennington Biomedical Research Center | 12 | 2009-10-01 | 2015-12-18 |
| The Effects of Smell on Mood and Physical Responses Exposure to relaxant and stimulant odors - Stress, Anxiety | Phase 1 | Completed | National Center for Complementary and Integrative Health (NCCIH) | 56 | 2005-08-01 | 2010-02-18 |
Anosmia (7) · Anxiety Disorders (2) · COVID-19 (2) · Depression (2) · Ageusia (1) · Arthritis, Reactive (1) · Bipolar Disorder (1) · COVID-19 stress syndrome (1) · Gastroesophageal Reflux (1) · Glomerulonephritis (1) · Guillain-Barre Syndrome (1) · Heartburn (1) · Hepatitis (1) · Infections (1)
Nervous System Diseases (8) · Neurologic Manifestations (8) · Pathological Conditions, Signs and Symptoms (8) · Sensation Disorders (8) · Signs and Symptoms (8) · Behavior (2) · Behavioral Symptoms (2) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Infections (2) · Lung Diseases (2) · Mental Disorders (2) · Nidovirales Infections (2) · Pneumonia (2)
Budesonide (1) · Diltiazem (1) · Insulin Aspart (1) · Mepivacaine (1) · Olfactory Training (1) · Prednisolone (1) · Zinc (1)
All Natural Medicine Clinic, LLC (1) · Amanda Stapleton (1) · Deraya University (1) · Ministry of Health, Saudi Arabia (1) · National Center for Complementary and Integrative Health (NCCIH) (1) · Pennington Biomedical Research Center (1) · University of Nebraska (1) · Washington University School of Medicine (1)
United States (5) · Egypt (1)
Amanda L Stapleton, MD (1) · Frank L. Greenway, MD (1) · Janice Kiecolt-Glaser, PhD (1) · Mara Seier, MD (1) · Wanzhu Hou, CMD (1)